ICML 2019 | Zanubrutinib in mantle cell lymphoma: updated safety and efficacy data

Constantine Tam

“Constantine Tam, MD, FRACP, FRCPA, Peter MacCallum Cancer Centre, Melbourne, Australia, presents the updates safety and efficacy data from the Phase I trial of zanubrutinib in mantle cell lymphoma (MCL). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video